Kết quả tìm kiếm - Azazuddin Ahmed

  • Đang hiển thị 1 - 4 kết quả của 4
Tinh chỉnh kết quả
  1. 1
    Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study

    Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycer... Bằng Serge Jabbour, Juan P. Frías, Cristian Guja, Elise Hardy, Azazuddin Ahmed, Peter Öhman

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  2. 2
    Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial

    Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Met... Bằng Serge Jabbour, Juan P. Frías, Elise Hardy, Azazuddin Ahmed, Hui Wang, Peter Öhman, Cristian Guja

    Được phát hành 2018
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  3. 3
    Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial

    Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial Bằng Serge Jabbour, Juan P. Frías, Azazuddin Ahmed, Elise Hardy, Jasmine Choi, C. David Sjöström, Cristian Guja

    Được phát hành 2020
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:
  4. 4
    Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

    Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial Bằng Bernard Zinman, Vanita R. Aroda, John B. Buse, Bertrand Cariou, Stewart B. Harris, Søren T. Hoff, Karen Boje Pedersen, Mads Jeppe Tarp-Johansen, Eiichi Araki, Bernard Zinman, Sameh Fikry, Harpreet S. Bajaj, Daniel Landry, David Caplan, Vincent Woo, Stewart B. Harris, Jean-Francois Thuan, Pierre Sérusclat, Bertrand Cariou, Pierre Gourdy, G. Fradet, Arnaud Monier, Sophie Borot, P. Monguillon, D. Gouet, John Doupis, Nikolaοs Tentolouris, V. Tsimichodimos, Andreas Melidonis, Eleni Bekiari, Αlexandra Bargiota, Sanjay Agarwal, Banshi Saboo, Sanjay Chatterjee, Viswanathan Mohan, Shehla Shaikh, Yashdeep Gupta, Arpandev Bhattacharyya, Neeraj Manikath, Sunil Jain, Takashi Sasaki, Takeshi Osonoi, Shuichi Fukuda, Seiki Wada, Arihiro Kiyosue, Yumiko Ide, Yukiko Onishi, Kiyokazu Matoba, Kuninobu Takai, Akira Yamauchi, Satoshi Inoue, Shizuka Kaneko, Hiroki Ikeda, Yasuharu Ohta, Akitaka Hisatomi, Takafumi Senokuchi, Hideaki Jinnouchi, Shuji Nakamura, José Roberto Lazcano Soto, Ignacio Rodríguez Briones, Paweł Bogdański, Ewa Szyprowska, Anna Modzelewska, Iwona Wozniak, S. T. Zyangirova, M. Sergeeva-Kondrachenko, Thomas R. A. Davis, Stephen P. Thomson, Juan P. Frías, Winston Gandy, Ildiko Lingvay, Kevin Pounds, Cynthia Bowman-Stroud, Michael Dempsey, David Huffman, Azazuddin Ahmed, Neil Fraser, Ramon Ortiz-Carrasquillo, D. Eric Bolster, Michael Adams, Matthew A. Hummel, Almena Free, Patricia Houser, Gerald Shockey, Otis Barnum, Kala R. Bhasker, George Mitchell Cornett, Dan Streja, William Kirby, Sean Lynd, Steven Folkerth, Samer Nakhle, Paul Norwood, Rodolfo Pérez, Brian D. Snyder, Neil Farris, Willian Litchfield, Osama Hamdy, Jean Park, Vanita R. Aroda

    Được phát hành 2019
    lấy văn bản lấy văn bản
    Artigo
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: